Pura Vida Investments, LLC 13D and 13G filings for Lyra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-15 09:18 am Sale |
2023-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Pura Vida Investments, LLC | 1,613,844 3.060% |
-543,454 (-25.19%) |
Filing |
| 2023-02-14 3:47 pm Sale |
2022-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Pura Vida Investments, LLC | 2,157,298 6.780% |
-624,793 (-22.46%) |
Filing |
| 2022-11-08 4:12 pm Purchase |
2022-05-20 | 13G | Lyra Therapeutics, Inc. LYRA |
Pura Vida Investments, LLC | 2,782,091 8.740% |
2,782,091 (New Position) |
Filing |